Advanced search
Publication Cover
Hematology Volume 28, 2023 - Issue 1
Submit an article Journal homepage
1,599
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Refractory cold agglutinin disease successfully treated with daratumumab. A case report and review of literature

Abdelaziz Mohameda Internal Medicine, Hamad Medical Corporation, Doha, QatarCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0009-0004-1927-659XView further author information
ORCID Icon,
Mohammed Alkhatiba Internal Medicine, Hamad Medical Corporation, Doha, QatarView further author information
,
Awni Alshurafab Hematology, Hamad Medical Corporation, Doha, QatarView further author information
&
Halima El Omrib Hematology, Hamad Medical Corporation, Doha, QatarView further author information
Article: 2252651 | Received 21 Jul 2023, Accepted 23 Aug 2023, Published online: 04 Sep 2023

References

  • Gabbard AP, Booth GS. Cold agglutinin disease. Clin Hematol Int. 2020 Sep;2(3):95–100. PMID: 34595449. doi:10.2991/chi.k.200706.001
  • Berentsen S, Ulvestad E, Langholm R, et al. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Haematologica. 2006 Apr;91(4):460–466.
  • Berentsen S. How I treat cold agglutinin disease. Blood. 2021 Mar;137(10):1295–1303. PMID: 33512410. doi:10.1182/blood.2019003809
  • Berentsen S, Ulvestad E, Gjertsen BT, et al. Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood. 2004 Apr;103(8):2925–2928. PMID: 15070665. doi:10.1182/blood-2003-10-3597
  • Tomkins O, Berentsen S, Arulogun S, et al. Daratumumab for disabling cold agglutinin disease refractory to B-cell directed therapy. Am J Hematol. 2020 Jul;95. PMID: 32652632. doi:10.1002/ajh.25932
  • Zaninoni A, Giannotta JA, Gallì A, et al. The immunomodulatory effect and clinical efficacy of daratumumab in a patient with cold agglutinin disease. Front Immunol 2021;12:649441. PMID: 33732266. doi:10.3389/fimmu.2021.649441
  • Berentsen S. Cold agglutinin disease. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):226–231. PMID: 27913484; PMCID: PMC6142439. doi:10.1182/asheducation-2016.1.226
  • Tolbert VP, Goldsby R, Huang J, et al. Daratumumab is effective in the treatment of refractory post-transplant autoimmune hemolytic anemia: a pediatric case report. Blood. 2016;128:4819. PMID: 36524117. doi:10.1182/blood.V128.22.4819.4819
  • Schuetz C, Hoenig M, Moshous D, et al. Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic. stem cell transplantation. Blood Adv. 2018;2:2550–2553. PMID: 30291113. doi:10.1182/bloodadvances.2018020883
  • Korver W, Carsillo M, Yuan J, et al. A reduction in B, T, and natural killer cells expressing CD38 by TAK-079 inhibits the induction and progession of collagen-induced arthritis in cynomolgus monkeys. Pharmacol Exp Ther. 2019;370:182–196. PMID: 31085699. doi:10.1124/jpet.119.256602
  • Pereda MA, Hosahalli Vasanna S, Desai NJ, et al. Case report: daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia. Front Immunol. 2022 Nov 29;13:1055473. PMID: 36524117; PMCID: PMC9744936. doi:10.3389/fimmu.2022.1055473
  • Vernava I, Schmitt CA. Daratumumab as a novel treatment option in refractory ITP. Blood Cells Mol Dis. 2023 Mar;99:102724. Epub 2023 Jan 13. PMID: 36669360. doi:10.1016/j.bcmd.2023.102724
  • Nooka AK, Gleason C, Sargeant MO, et al. Managing infusion reactions to new monoclonal antibodies in multiple myeloma: daratumumab and elotuzumab. J Oncol Pract. 2018 Jul;14(7):414–422. PMID: 29996069. doi:10.1200/JOP.18.00143
  • Sullivan HC, Gerner-Smidt C, Nooka AK, et al. Daratumumab (anti-CD38) induces loss of CD38 on red blood cells. Blood. 2017 Jun 1;129(22):3033–3037. Epub 2017 Apr 3. PMID: 28373263; PMCID: PMC5454337. doi:10.1182/blood-2016-11-749432
  • Werle E, Ziebart J, Wasmund E, et al. Daratumumab interference in pretransfusion testing Is overcome by addition of daratumumab Fab fragments to patients’ plasma. Transfus Med Hemother. 2019 Dec;46(6):423–430. Epub 2019 Mar 12. PMID: 31933572; PMCID: PMC6944924. doi:10.1159/000495773

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.